Tambet Teesalu Selected Research

N-end cysteine peptide tumor-homing peptide

1/2021	Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting.
10/2016	iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
1/2015	Tumor-penetrating iRGD peptide inhibits metastasis.
1/2013	De novo design of a tumor-penetrating peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tambet Teesalu Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 04/2003
9	Breast Neoplasms (Breast Cancer) 10/2021 - 07/2015
7	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 04/2003
7	Carcinoma (Carcinomatosis) 01/2021 - 04/2011
6	Peritoneal Neoplasms 05/2018 - 08/2015
5	Prostatic Neoplasms (Prostate Cancer) 04/2016 - 09/2009
4	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2015
2	Infections 01/2022 - 02/2018
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2021 - 01/2016
2	COVID-19 08/2021 - 11/2020
2	Glioma (Gliomas) 01/2021 - 11/2017
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 04/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 11/2017
2	Melanoma (Melanoma, Malignant) 11/2017 - 04/2016
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 04/2005 - 10/2003
1	Body Weight (Weight, Body) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Endometriosis 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Adenocarcinoma 01/2021
1	Myocardial Infarction 01/2020
1	Epidermolysis Bullosa 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Multiple Sclerosis 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Triple Negative Breast Neoplasms 04/2018
1	Staphylococcal Infections 02/2018
1	Gliosis 11/2017
1	Neuroinflammatory Diseases 11/2017

Drug/Important Bio-Agent (IBA)

46	Peptides (Polypeptides)IBA 01/2022 - 09/2009
10	Neuropilin-1IBA 01/2022 - 12/2009
10	Pharmaceutical PreparationsIBA 01/2021 - 09/2009
8	LigandsIBA 11/2021 - 04/2016
7	Proteins (Proteins, Gene)FDA Link 03/2021 - 10/2003
6	IntegrinsIBA 01/2021 - 12/2009
5	TenascinIBA 11/2021 - 10/2019
4	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 04/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 01/2013
4	N-end cysteine peptide tumor-homing peptideIBA 01/2021 - 01/2013
4	ferric oxide (iron oxide)IBA 01/2020 - 01/2017
3	Fibronectins (Fibronectin)IBA 11/2021 - 10/2019
3	AntibodiesIBA 01/2021 - 01/2013
3	SilverIBA 01/2020 - 05/2017
3	Antineoplastic Agents (Antineoplastics)IBA 02/2013 - 12/2009
2	Peptide Receptors (Peptide Receptor)IBA 10/2021 - 04/2016
2	Mannose ReceptorIBA 10/2021 - 11/2017
2	Liposomes (Liposome)IBA 03/2021 - 01/2016
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 08/2015
2	AntigensIBA 01/2021 - 08/2013
2	LipidsIBA 01/2018 - 07/2015
2	Albumin-Bound Paclitaxel FDA Link 10/2016 - 01/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2016 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 01/2013
2	NeuropilinsIBA 08/2015 - 01/2015
2	Contrast MediaIBA 07/2015 - 01/2013
2	Neurofibromin 2 (Merlin)IBA 04/2005 - 10/2003
2	radixinIBA 04/2005 - 10/2003
2	ezrinIBA 04/2005 - 10/2003
2	moesinIBA 04/2005 - 10/2003
1	Serine (L-Serine)FDA Link 01/2022
1	EnzymesIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	Epidermal Growth Factor (EGF)IBA 10/2021
1	Biological ProductsIBA 10/2021
1	Therapeutic UsesIBA 10/2021
1	resiquimodIBA 10/2021
1	Messenger RNA (mRNA)IBA 08/2021
1	Small Interfering RNA (siRNA)IBA 08/2021
1	patisiranIBA 08/2021
1	nasIBA 08/2021
1	mRNA VaccinesIBA 08/2021
1	Nucleic AcidsIBA 08/2021
1	Sorafenib (BAY 43-9006)FDA Link 03/2021
1	peptide AIBA 03/2021
1	AnthracyclinesIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2020
1	Atrial Natriuretic Factor (ANF)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Peptide LibraryIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	polycaprolactoneIBA 04/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2018
1	Vancomycin FDA LinkGeneric 02/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2018
1	KLA peptideIBA 12/2017
1	Hyaluronic Acid (Hyaluronan)IBA 05/2017

Therapy/Procedure

19	Therapeutics 11/2021 - 05/2010
3	Drug Therapy (Chemotherapy) 10/2021 - 08/2015
2	Precision Medicine 12/2017 - 01/2017
2	Investigational Therapies (Experimental Therapy) 01/2017 - 01/2016
1	Immunotherapy 01/2020
1	Micro-Electrical-Mechanical Systems 11/2017